Knott David M Jr »

Travere Therapeutics shares owned by Knott David M Jr

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2023-09-30 $897k 100k 8.94

More positions owned by Knott David M Jr

Calumet Specialty Products Partners Common (CLMT)
Apollo Global Management Common (APO)
FTAI Aviation Common (FTAI)
Alphabet Inc-Cl C Common (GOOG)
DocGo Common (DCGO)
Midwest Holding Common
Ligand Pharmaceuticals Incorporated Common (LGND)
Ardelyx Common (ARDX)
Coliseum Acquisition Corp. Wts Common (MITAW)
OmniAb Common (OABI)
CALLS/Calumet Specialty Product @20 ex1/24 Common
Franklin BSP Realty Trust Common (FBRT)
Seagen Common
Pfizer Common (PFE)
Panagram BBB-B CLO ETF Common (CLOZ)

View all positions for Knott David M Jr

Top funds holding Travere Therapeutics

Vanguard Group
Deutsche Bank Aktiengesellschaft
Kynam Capital Management
Jacobs Levy Equity Management
D. E. Shaw & Co
Bank of America Corporation
Goldman Sachs Group
Millennium Management
Emerald Advisers
Avidity Partners Management
Emerald Mutual Fund Advisers, Trust
Schonfeld Strategic Advisors
Barclays
Healthcare Of Ontario Pension Plan Trust Fund
Two Sigma Advisers

View all funds holding Travere Therapeutics